Criteria for the classification of early systemic sclerosis.
about
Immunotherapy of systemic sclerosisCurrent perspectives on the immunopathogenesis of systemic sclerosisMiRNA in atopic dermatitisSelected Aspects in the Pathogenesis of Autoimmune DiseasesScleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvementRenal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and managementCellular Therapies in Systemic Sclerosis: Recent ProgressIdentification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyN-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyThe 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR CenterThe pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expressionAbnormalities in the regulators of angiogenesis in patients with sclerodermaDisturbed microcirculation in the hands of patients with systemic sclerosis detected by fluorescence optical imaging: a pilot studyComparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertensionHigh serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathologyEarly systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments.Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis.Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosisDecreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosisAssessment of daily life physical activities in pulmonary arterial hypertension.Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolEgr-ly awaiting a "personalized medicine" approach to treat scleroderma.Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature.Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Cells from a vanished twin as a source of microchimerism 40 years laterPotential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.Systemic sclerosis in a patient with pityriasis rubra pilaris.Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.Platelet-derived serotonin links vascular disease and tissue fibrosis.Pulmonary arterial hypertension associated with systemic sclerosis.Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis
P2860
Q24634395-76954824-33E8-4FD2-A9DF-E92D73258975Q26741264-15BCEEDF-E7F9-4D7B-9520-0D362EE991BFQ26741930-66A77F28-3975-4562-959B-6187D2E54A75Q26795580-D8E8DD6C-D6EF-431C-8A97-109F133BBF33Q26995764-C59864E2-A4F4-48C8-8E94-1A14D878B998Q27023769-2D7DC200-0738-4CDD-9CB5-733E9D019133Q28080323-A8A8FA44-71E4-43DD-8C1F-B6B9C4F1EAF2Q28397539-AF233FFA-FB14-42C2-844E-76DE7EB31DA6Q29417020-7EFEDCD6-306B-4758-8EC3-87C8F72EDBF6Q30463476-76E0E8B6-C494-4E0F-9663-824B7D6133C8Q31142593-F8705BF2-1C9F-456F-873D-5C4D950239C1Q33470222-A22DEE71-0C7D-4F97-9EC9-7EF003109719Q33471458-200CFF19-840C-4D34-9EE2-1273B8B5402AQ33606645-27B15DAE-1312-4D35-8078-2C2EED1136C7Q33651547-2E619230-1720-4145-B064-DE06E1309056Q33653005-33861C73-9CC0-4C2A-8F4C-395BE6D336F2Q33759804-843B09CD-F998-412C-BB19-BD0F2D8192C0Q33765551-DEB4902C-F9E7-42F0-A128-23FCC694E7A7Q33765558-BAB459BB-510A-4BA4-9332-E7893E316D50Q33766384-CCDFA6D6-4447-4F49-94DD-A7E2ECDDABD9Q33783722-060A07A1-066C-482A-BB0F-8B272FE6073AQ33847277-6F510AB6-463D-4963-91FA-009810D158CBQ33923321-6289A608-DF9B-4344-9D31-8D821817D86DQ33947213-A2F91A9C-5A91-4164-807A-643ADB74615AQ34010829-A5D24867-9982-43BE-936D-CD0071B44E11Q34081843-5A601799-FC69-451B-AEEE-1D0A750B5792Q34107962-F0D14888-D336-48D6-A57A-6BC5A5EAFA9BQ34152046-9AAE6AD2-4FA1-438F-97F8-D3C2D267B5D0Q34164828-4B249E8D-E6FB-4460-B6CB-0BF52824209FQ34283946-08AEA68E-D446-4183-90CC-23C57341B487Q34352783-E3204F9E-2786-42EB-9F3D-34ECC6F18186Q34385555-B36E7B8E-0BAE-46AA-9CC1-B379A149DE75Q34503686-043C87A3-FE47-4FE6-86FA-4A8C7F223D45Q34503687-D1B6F3EC-51DC-49A0-ACB6-DBC66830D806Q34687497-5370D549-A4EA-4990-96F9-0D41D10EA699Q34714221-A8E3E6A9-9A6D-44FC-BA0F-B3D2238CAE22Q34775608-0990A5F4-F814-4DE0-80FD-56BB1E23DB58Q34973681-53933A6E-319D-4E84-B09C-AC893980EC84Q35002423-EA22A6ED-C7C5-458D-88E6-F78E1A78341CQ35035897-5EEA6375-743A-45EA-86FB-50EA68B860A4
P2860
Criteria for the classification of early systemic sclerosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Criteria for the classification of early systemic sclerosis.
@ast
Criteria for the classification of early systemic sclerosis.
@en
Criteria for the classification of early systemic sclerosis.
@nl
type
label
Criteria for the classification of early systemic sclerosis.
@ast
Criteria for the classification of early systemic sclerosis.
@en
Criteria for the classification of early systemic sclerosis.
@nl
prefLabel
Criteria for the classification of early systemic sclerosis.
@ast
Criteria for the classification of early systemic sclerosis.
@en
Criteria for the classification of early systemic sclerosis.
@nl
P1476
Criteria for the classification of early systemic sclerosis
@en
P2093
Medsger TA Jr
P304
P407
P577
2001-07-01T00:00:00Z